The overall survival of MDA-MB-231-FFluc or HCT116-FFluc tumor-bearing mice was significantly prolonged in the treatment groups, including B7-H3 CAR-T cells treatment, JK184 treatment and combinatorial therapy (Fig. 5B and G). The gene discussed is CD276; the disease is neoplasm.